ArticleNeurological research and practice2025

A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months.

Shiho Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.